Laboratory Corporation of America Holdings $400,000,000 2.300% Senior Notes Due 2024 $650,000,000 2.950% Senior Notes Due 2029 Underwriting AgreementLaboratory Corp of America Holdings • November 19th, 2019 • Services-medical laboratories • New York
Laboratory Corporation of America Holdings, a corporation organized under the laws of Delaware (the “Company”), proposes to sell to the several underwriters named in Schedule II hereto (the “Underwriters”), for whom you (“you” or the “Representatives”) are acting as representatives, the principal amount of its notes identified in Schedule I hereto (the “Notes”), to be issued under an indenture dated as of November 19, 2010 as supplemented by the Thirteenth Supplemental Indenture to be dated November 25, 2019 and the Fourteenth Supplemental Indenture to be dated November 25, 2019 (collectively, the “Indenture”), each between the Company and U.S. Bank National Association, as trustee (the “Trustee”). To the extent there are no additional Underwriters named in Schedule II other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters shall mean either the singular or plural as the context requires. Any reference here
